25 Percent Quarterly Revenue Growth Stocks to Buy in November 2026: 5 Names on the Watchlist

The 25 percent quarterly revenue growth stocks to buy in November 2026 start with five listed names: Bank of Maharashtra, Cholamandalam Investment and Finance, Divi's Laboratories, KFin Technologies and Uno Minda. These five companies each grew revenue by about 22% to 28% in the September 2026 quarter compared with a year earlier. Divi's Laboratories is part of the Nifty Pharma index.

This article ranks none of them as a sure thing. It lays out the numbers each company has reported, how the shares are priced today and what an investor should check before adding any of these 25 percent quarterly revenue growth stocks to buy to a portfolio. All prices are NSE closing prices of 9 November 2026, and financials come from company filings.

Click Here – Get Free Investment Predictions

Which Are the Best 25 Percent Quarterly Revenue Growth Stocks to Buy in November 2026?

The best 25 percent quarterly revenue growth stocks to buy in November 2026 for a watchlist are Bank of Maharashtra, Cholamandalam Investment and Finance, Divi's Laboratories, KFin Technologies and Uno Minda. They were picked because each has complete reported financials, profit in the latest quarter and an NSE listing. The table puts their market data side by side.

Company	CMP (Rs)	Market Cap	P/E	ROE	Dividend Yield
Bank of Maharashtra	87.68	Rs 62,225 crore	7.77	22.53%	1.48%
Cholamandalam Investment and Finance	1,791	Rs 1,37,140 crore	22.04	18.02%	0.12%
Divi's Laboratories	11,566	Rs 2,56,310 crore	87.63	15.32%	0.31%
KFin Technologies	914.50	Rs 14,910 crore	42.76	21.47%	1.39%
Uno Minda	1,354	Rs 63,290 crore	49.04	17.53%	0.24%

On valuation, Bank of Maharashtra trades below the industry P/E; KFin Technologies sits close to it; Cholamandalam Investment and Finance, Divi's Laboratories and Uno Minda carry a premium. Valuation is the first filter for any 25 percent quarterly revenue growth stocks to buy list, and it is covered again in the risk section.

Why These 25 Percent Quarterly Revenue Growth Stocks to Buy Are in Focus

In this list, FY26 net profit and revenue both grew for every company, and quarterly profit in the September 2026 quarter was higher than a year earlier for all five. The list covers a public sector bank, a vehicle finance company, a pharma ingredients maker, a registrar for mutual funds and an auto components maker. Investors comparing the best stocks with 25 percent quarterly revenue growth in India usually check whether sales growth turns into profit, how the shares are valued and how much debt the company carries.

Bank of Maharashtra: The Growing Public Sector Bank Among 25 Percent Quarterly Revenue Growth Stocks to Buy

Bank of Maharashtra is a public sector bank with a strong presence in Maharashtra and a growing loan book. The stock trades at Rs 87.68 with a market capitalisation of Rs 62,225 crore and a P/E of 7.77, against an industry P/E of 11.45.

FY26 revenue rose 15.6% to Rs 32,824 crore and net profit rose 26.6% to Rs 7,017 crore. In the September 2026 quarter, revenue grew 22.1% year on year to Rs 9,736 crore, while net profit grew 41.4% to Rs 2,310 crore.

Return on equity is 22.53%, and the dividend yield is 1.48%. Promoters hold 73.60%, foreign institutions 6.51% and domestic institutions 13.77% as of September 2026. Domestic institutional holding has risen from 10.05% to 13.77% over the last year.

Cholamandalam Investment and Finance: The Vehicle Finance Specialist Among 25 Percent Quarterly Revenue Growth Stocks to Buy

Cholamandalam Investment and Finance is a vehicle finance, home loan and small business lender in the Murugappa Group. At Rs 1,791, the stock has a market capitalisation of Rs 1,37,140 crore and trades at 22.04 times earnings, while the industry P/E is 16.15.

Reported numbers show FY26 revenue of Rs 31,539 crore, up 20.6% year on year, with net profit at Rs 5,229 crore, up 22.7%. The September 2026 quarter added revenue of Rs 9,395 crore (up 23.4%) and net profit of Rs 1,630 crore (up 40.6%).

Return on equity is 18.02%, and the dividend yield is 0.12%. Promoters hold 48.93%, foreign institutions 24.87% and domestic institutions 20.38% as of September 2026. Domestic institutional holding has risen from 17.27% to 20.38% over the last year.

Check 25 Percent Quarterly Revenue Growth Stocks Live on the Univest Screener

Divi's Laboratories: The API Specialist Among 25 Percent Quarterly Revenue Growth Stocks to Buy

Divi's Laboratories is a contract manufacturer of active pharmaceutical ingredients and intermediates for global drug makers. Its market capitalisation is Rs 2,56,310 crore, the share price is Rs 11,566 and the P/E of 87.63 compares with an industry P/E of 37.65.

Over FY26, net profit rose 17.2% to Rs 2,568 crore on revenue of Rs 11,067 crore, which was up 14.0%. The latest quarter, the June 2026 quarter, brought revenue of Rs 3,144 crore, up 24.3% year on year, and net profit of Rs 902 crore, up 65.5%.

Return on equity is 15.32%, debt-to-equity is 0.00, and the dividend yield is 0.31%. Promoters hold 51.88%, foreign institutions 20.38% and domestic institutions 19.17% as of September 2026. A point to keep in view: at a P/E of 87.63, expectations are already high.

KFin Technologies: The Registrar and Technology Name Among 25 Percent Quarterly Revenue Growth Stocks to Buy

KFin Technologies is a registrar and technology services company for mutual funds and issuers. The stock trades at Rs 914.50 with a market capitalisation of Rs 14,910 crore and a P/E of 42.76, against an industry P/E of 42.66.

FY26 revenue rose 19.1% to Rs 1,344 crore and net profit rose 3.3% to Rs 344 crore. In the September 2026 quarter, revenue grew 28.1% year on year to Rs 410 crore, while net profit grew 7.5% to Rs 100 crore.

Return on equity is 21.47%, and the dividend yield is 1.39%. Promoters hold 14.06%, foreign institutions 20.07% and domestic institutions 37.55% as of September 2026. Domestic institutional holding has risen from 24.80% to 37.55% over the last year.

Uno Minda: The Component Supplier Among 25 Percent Quarterly Revenue Growth Stocks to Buy

Uno Minda is a component supplier with electronics and EV-related products. At Rs 1,354, the stock has a market capitalisation of Rs 63,290 crore and trades at 49.04 times earnings, while the industry P/E is 36.13.

Reported numbers show FY26 revenue of Rs 19,692 crore, up 17.2% year on year, with net profit at Rs 1,284 crore, up 25.8%. The June 2026 quarter added revenue of Rs 5,563 crore (up 23.6%) and net profit of Rs 316 crore (up 2.1%).

Return on equity is 17.53%, debt-to-equity is 0.40, and the dividend yield is 0.24%. Promoters hold 68.36%, foreign institutions 8.78% and domestic institutions 17.11% as of September 2026. Domestic institutional holding has risen from 15.80% to 17.11% over the last year.

Download the Univest iOS App or Univest Android App to track these 25 percent quarterly revenue growth stocks live and get daily stock recommendations.

Growth Snapshot: Latest Full Year and Latest Quarter

The table compares year-on-year growth in revenue and net profit for all five 25 percent quarterly revenue growth stocks, using filed results.

Company	Full-Year Revenue Growth	Full-Year Profit Growth	Latest Quarter	Quarter Revenue Growth	Quarter Profit Growth
Bank of Maharashtra	15.6%	26.6%	Sep 2026	22.1%	41.4%
Cholamandalam Investment and Finance	20.6%	22.7%	Sep 2026	23.4%	40.6%
Divi's Laboratories	14.0%	17.2%	Jun 2026	24.3%	65.5%
KFin Technologies	19.1%	3.3%	Sep 2026	28.1%	7.5%
Uno Minda	17.2%	25.8%	Jun 2026	23.6%	2.1%

Factors That Move 25 Percent Quarterly Revenue Growth Stocks to Buy

Four factors tend to drive 25 percent quarterly revenue growth stocks, and each one is worth checking before a purchase.

• Quarterly growth: Revenue rose about 22% to 28% year on year.
• Dividends: Bank of Maharashtra yields about 1.5%.
• Return on equity: Bank of Maharashtra leads at about 23%.
• Valuation: P/E runs from about 8 to 88.

Risks to Keep in Mind Before Buying 25 Percent Quarterly Revenue Growth Stocks

The first risk is that Divi's Laboratories trades at a P/E near 88 while Bank of Maharashtra trades near 8, so expectations differ widely. The second is that Cholamandalam Investment and Finance carries the highest borrowings of the five as a lender. Check results every quarter.

On the numbers, Divi's Laboratories trades at the highest P/E on this list at 87.63, so its earnings need to keep growing to support the price. 25 Percent Quarterly Revenue Growth stocks to buy can still fall when markets turn weak, and a staggered entry has historically suited investors better than a lump-sum purchase.

How to Choose 25 Percent Quarterly Revenue Growth Stocks to Buy

• Compare growth: Bank of Maharashtra grew FY26 profit most, by about 27%.
• Check P/E: Bank of Maharashtra trades lowest.
• Read ROE: Bank of Maharashtra leads.
• Spread sectors: Mix banking, lending, pharma, market services and auto parts.

How to Invest in 25 Percent Quarterly Revenue Growth Stocks

1. Shortlist two or three companies from this list that match your risk appetite.
2. Open the Univest Screener and compare P/E, ROE and debt for each stock.
3. Check the latest quarterly results and shareholding pattern on NSE or BSE.
4. Decide an amount you can hold for three to five years and split it into two or three purchases.
5. Review the holding after every quarterly result instead of reacting to daily price moves.

Conclusion

Bank of Maharashtra offers both the lowest P/E on this list at 7.77 and the highest return on equity at 22.53%, and Bank of Maharashtra posted the fastest net profit growth in its latest full year at 26.6%. Among the best 25 percent quarterly revenue growth stocks in India, these five give investors a spread of size, valuation and growth, so the right pick depends on risk appetite and holding period. Spread the entry, keep position sizes sensible and consult a SEBI-registered advisor before investing in any of these 25 percent quarterly revenue growth stocks to buy.

Frequently Asked Questions on 25 Percent Quarterly Revenue Growth Stocks to Buy

Which are the best 25 percent quarterly revenue growth stocks to buy in November 2026?

Ans. The five 25 percent quarterly revenue growth stocks on the November 2026 watchlist are Bank of Maharashtra, Cholamandalam Investment and Finance, Divi's Laboratories, KFin Technologies and Uno Minda. Bank of Maharashtra has both the lowest P/E at 7.77 and the highest ROE at 22.53%, and Bank of Maharashtra grew net profit 26.6% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.

Is Divi's Laboratories a good stock to buy from this 25 Percent Quarterly Revenue Growth list?

Ans. Divi's Laboratories is the largest company on this list with a market capitalisation of Rs 2,56,310 crore and a P/E of 87.63 against an industry P/E of 37.65. Its FY26 revenue rose 14.0% and net profit rose 17.2%, with return on equity at 15.32%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.

Are these 25 percent quarterly revenue growth stocks expensive right now?

Ans. Valuations vary across the group. Bank of Maharashtra trades at a P/E of 7.77, Cholamandalam Investment and Finance trades at a P/E of 22.04, Divi's Laboratories trades at a P/E of 87.63, KFin Technologies trades at a P/E of 42.76, Uno Minda trades at a P/E of 49.04, against industry multiples ranging from 11.45 to 42.66. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.

Which of these 25 percent quarterly revenue growth stocks pay a dividend?

Ans. Dividend yields on this list are Bank of Maharashtra 1.48%, Cholamandalam Investment and Finance 0.12%, Divi's Laboratories 0.31%, KFin Technologies 1.39%, Uno Minda 0.24%. Yields are modest across the group, so most investors look at these stocks for growth in earnings rather than for income, and payouts can change with company profits.

Which stock on this list has the highest return on equity?

Ans. Bank of Maharashtra has the highest ROE on this list at 22.53%, followed by KFin Technologies at 21.47% and Cholamandalam Investment and Finance at 18.02%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.

What are the risks of investing in 25 percent quarterly revenue growth stocks?

Ans. The main risks are funding costs at the lender, one very high valuation and asset quality at the bank. On this list, Divi's Laboratories trades at the highest P/E of 87.63, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.

How can I invest in 25 percent quarterly revenue growth stocks in India?

Ans. You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.